Multiple Sclerosis
Conditions
Keywords
multiple sclerosis, individual exercise, fatigue, traditional exercise
Brief summary
The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.
Detailed description
Chronic fatigue is a very common symptom reported (80%) by patients with multiple sclerosis (MS), regardless of the type of MS and level of disability. Despite the clinical importance of MS-related fatigue, pharmacological treatments remain quite ineffective in preventing or treating chronic fatigue. Recently, physical activity has proven to be an effective therapy with benefits on chronic fatigue as well as on different functions (muscular, cardiorespiratory, cognitive, etc.). Nevertheless, the effects of physical exercise may vary between MS patients, as MS is a heterogeneous disease and does not affect each individual in the same way. The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.
Interventions
OTHERAdapted and individualized physical training program
Physical training program adapted and individualized according to each patient in this group
Same training program for all patients in this group
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Aged 18 to 70 years old * Male or female * With relapsing-remitting multiple sclerosis (RRMS) as defined by McDonald's 2010 criteria. * Between 2 and 25 years from the onset of multiple sclerosis * With a high level of fatigue, corresponding to a score of Fatigue Severity Scale\> 4 and Fatigue questionnaire \> 38. * Expanded Disability Status Scale Score 5 * Testing ≥ 4 in all leg muscles. * Ability to walk for 10 minutes without stopping (self-reported) * Affiliates or beneficiaries of a social security scheme * Having freely given their written consent after having been informed of the purpose, course of action and potential risks involved
Exclusion criteria
* Severe cerebellar spasticity or ataxia in either leg. * Abnormal range of motion of the toes and/or ankle. * Musculoskeletal injury that interferes with pedaling. * High resting heart rate (\>90 beats per minute). * Blood pressure \> 144/94 mmHg. * Onset of a multiple sclerosis attack within 90 days prior to the study. * Recent adjustment of any medication or drugs that may impact on fatigue, or taking stimulants for fatigue (e.g. Modafinil). * Taking of neuro-active substances that may impair cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) throughout the study period. * Contraindication to the application of a magnetic field * History of co-morbid disease or conditions that would compromise the subject's safety during the study. * Participation at the same time in another medical intervention study or having participated in such a study within 30 days prior to this study. * Pregnant and Nursing Women * Women of childbearing age without effective contraception * Patient unable to understand the purpose and conditions of the study, incapable of giving consent * Patient deprived of liberty or patient under guardianship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Chronic fatigue score | Month 3 | assessed using the Fatigue Severity Scale (FSS) questionnaire before and after an individualized re-training program compared to a traditional re-training program in MS patients. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hematological parameters | Month 3 | red blood cell and hemoglobin levels measured by spectrophotometry. |
| Inflammatory parameters | Month 3 | c-reactive protein |
| quality of sleep | Month 3 | actigraphy measurements and sleep diary records |
| cortical activation level | Month 3 | transcranial magnetic stimulation |
| cortico-spinal excitability | Month 3 | transcranial magnetic stimulation |
| cardiorespiratory fitness | Month 3 | evaluated by measuring the maximum oxygen consumption (VO2max) during an incremental exercise on a cycloergometer. |
| Analysis overall quality of life : Fatigue questionnaire | Month 3 | Fatigue questionnaire by Modified Fatigue Impact Scale (MFIS) results |
| Analysis overall quality of life :Quality of Life | Month 3 | Quality of Life Questionnaire by SEP-59 results |
| Analysis overall quality of life :Depression | Month 3 | Depression Questionnaire by Center for Epidemiologic Studies Depression (CES-D) results |
| Analysis overall quality of life : Sleep Quality | Month 3 | Sleep Quality Questionnaire by Pittsburgh Sleep Quality Index (PSQ-I) results |
| Analysis overall quality of life : Physical Activity | Month 3 | Physical Activity Questionnaire by Godin Leisure-Time Exercise Questionnaire (GLTEQ) results |
| neuromuscular fatigue of peripheral function | Month 3 | electrical nerve stimulation |
Countries
France
Outcome results
None listed